Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
|
| |
|
| Trading Volume | 25,507 |
|
|
61.30 - 16.92 |
| Market Cap Full | $ 3.2B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 3.3% | 28.5% | -1.6% | -14% |
| Q2 | - | -32.7% | 75.1% | 22.9% |
| Q3 | - | 1.1% | 8.7% | -95.7% |
| Q4 | - | -29.5% | 77.7% | 120.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 3.9 | 8 | 14.5 | -29.1 | -10 | -0.3 | 12.4 | 1.1 | - | - | - | -18.9 |
| 2023 | |||||||||||
| 37.3 | -19.8 | -10.6 | -4.3 | 34 | 36.5 | -17 | -7.8 | 41.9 | 2.1 | 25.6 | 28.4 |
| 2022 | |||||||||||
| -5.7 | -8.7 | -0.1 | -24.8 | 61.2 | 1.4 | 0.3 | 2.2 | -95.8 | 163 | -4.5 | -12.3 |
| 2021 | |||||||||||
| -0.6 | -0.3 | -19.6 | 9.9 | 15.9 | 11.6 | 29.8 | 4.2 | 4.8 | 2.9 | -20.7 | 22.8 |
| 2020 | |||||||||||
| -14.2 | -9.9 | -19.9 | 38.4 | 32.6 | 17 | -12.4 | -1 | 2.7 | 19 | 12.9 | -2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1 | 0 | -4.3 | -3.1 |
| Q2 | -1.3 | 0 | -3.2 | -3.1 |
| Q3 | -1.5 | 0 | -2.6 | -3.3 |
| Q4 | 0 | -1.8 | -5.4 | -3.6 |
| A | -3.85 | -12.8 | -5.4 | -3 |